Journey Medical (DERM) Stock Chart & Stock Price History $7.06 -0.12 (-1.60%) As of 10:16 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Journey Medical Stock Price Performance The Journey Medical (DERM) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 31.56%, with a year-to-date return of 80.69%. In the past month, the stock has decreased 12.34%, reflecting recent market activity. As of the latest close, Journey Medical traded at $7.18 with a market cap of $167.29 million and volume of 134,465 shares. Receive DERM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.93%1 Month Performance-12.34%3 Month Performance+18.34%Year-To-Date Performance+80.69%1 Year Performance+31.56% DERM Stock Chart for Tuesday, July, 1, 2025 DERM Chart by TradingView Journey Medical Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/30/2025$7.14$7.18+0.56%$7.28$6.89134,465 shs$167.29 million06/27/2025$7.00$7.14+2.00%$7.21$6.941.60 million shs$166.36 million06/26/2025$6.97$7.00+0.43%$7.02$6.8066,673 shs$163.10 million06/25/2025$6.95$6.97+0.29%$7.03$6.8089,203 shs$162.40 million06/24/2025$6.38$6.95+8.93%$7.15$6.57113,882 shs$161.94 million06/23/2025$6.51$6.38-2.00%$6.63$6.22134,083 shs$148.65 million06/20/2025$6.35$6.51+2.52%$6.71$6.23192,301 shs$151.68 million06/19/2025$6.35$6.35$6.58$6.22103,461 shs$147.96 million06/18/2025$6.31$6.35+0.63%$6.58$6.22103,461 shs$147.96 million06/17/2025$6.74$6.31-6.38%$6.87$6.2989,158 shs$147.00 million Get the Latest News and Ratings for DERM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. 06/16/2025$6.78$6.74-0.59%$6.92$6.6552,243 shs$157.02 million06/13/2025$6.97$6.78-2.73%$7.13$6.7671,022 shs$157.95 million06/12/2025$6.91$6.97+0.87%$7.09$6.8848,820 shs$162.37 million06/11/2025$7.30$6.91-5.34%$7.37$6.8970,541 shs$160.98 million06/10/2025$7.16$7.30+1.96%$7.36$7.00100,482 shs$170.06 million06/09/2025$7.39$7.16-3.11%$7.48$7.04113,507 shs$166.80 million06/06/2025$7.54$7.39-1.99%$7.75$7.3255,571 shs$172.16 million06/05/2025$7.45$7.54+1.21%$7.65$7.2872,231 shs$175.65 million06/04/2025$7.20$7.45+3.47%$7.58$7.16170,617 shs$173.56 million06/03/2025$7.81$7.20-7.81%$7.79$7.01215,890 shs$167.73 million06/02/2025$8.06$7.81-3.10%$8.25$7.63177,580 shs$181.94 million05/30/2025$8.07$8.06-0.12%$8.17$7.8257,104 shs$187.77 million Related Companies KalVista Pharmaceuticals Stock Chart Evolus Stock Chart Sana Biotechnology Stock Chart Upstream Bio Stock Chart Sage Therapeutics Stock Chart Altimmune Stock Chart Tango Therapeutics Stock Chart Keros Therapeutics Stock Chart Relay Therapeutics Stock Chart Autolus Therapeutics Stock Chart Receive DERM Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DERM) was last updated on 7/1/2025 by MarketBeat.com Staff From Our PartnersThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold prediction: $5,000/oz. or higher is comingThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Journey Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Journey Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
